TipRanks
BioRegenx (BRGX)
OTHER OTC:BRGX
US Market

BioRegenx (BRGX) Ratios

24 Followers

BioRegenx Ratios

BRGX's free cash flow for Q1 2026 was $0.82. For the 2026 fiscal year, BRGX's free cash flow was decreased by $ and operating cash flow was $-0.12. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
0.05 0.06 0.08 0.00 0.01
Quick Ratio
0.02 0.04 0.05 0.00 0.01
Cash Ratio
0.01 0.02 0.02 0.00 0.01
Solvency Ratio
-0.25 -0.30 -5.36 -2.23 -0.28
Operating Cash Flow Ratio
<0.01 <0.01 -0.09 -0.05 -1.00
Short-Term Operating Cash Flow Coverage
0.01 0.02 -0.17 -0.06 -1.43
Net Current Asset Value
$ -4.68M$ -4.70M$ -3.58M$ -253.61K$ -260.01K
Leverage Ratios
Debt-to-Assets Ratio
6.42 5.39 4.26 7.12 4.07
Debt-to-Equity Ratio
-0.48 -0.49 -0.64 -1.02 -1.20
Debt-to-Capital Ratio
-0.91 -0.95 -1.78 66.32 6.11
Long-Term Debt-to-Capital Ratio
-0.04 -0.04 -0.08 0.00 -34.17
Financial Leverage Ratio
-0.07 -0.09 -0.15 -0.14 -0.29
Debt Service Coverage Ratio
-0.15 -0.26 -10.35 -2.38 -1.60
Interest Coverage Ratio
-1.24 1.73 -78.32 -13.29 0.00
Debt to Market Cap
0.37 0.18 0.26 0.03 0.02
Interest Debt Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
-6.27 -4.83 -0.09 -0.40 -3.32
Profitability Margins
Gross Profit Margin
81.90%81.08%70.85%73.33%85.93%
EBIT Margin
-21.30%-27.99%-972.79%-2531.13%-185.74%
EBITDA Margin
-19.14%-23.94%-972.78%-2504.46%-171.67%
Operating Profit Margin
-21.30%-27.99%-972.79%-494.54%-185.74%
Pretax Profit Margin
-73.81%-83.23%-985.21%-2567.10%-185.74%
Net Profit Margin
-73.80%-83.23%-985.21%-2567.10%-185.74%
Continuous Operations Profit Margin
-73.81%-83.23%-985.21%-2567.10%-185.74%
Net Income Per EBT
99.99%100.00%100.00%100.00%100.00%
EBT Per EBIT
346.45%297.42%101.28%519.09%100.00%
Return on Assets (ROA)
-386.56%-375.58%-4533.41%-1804.68%-132.39%
Return on Equity (ROE)
31.83%34.02%682.22%257.24%38.85%
Return on Capital Employed (ROCE)
10.30%14.20%728.51%49.56%1366.39%
Return on Invested Capital (ROIC)
22.55%31.98%1873.53%-3237.20%-198.61%
Return on Tangible Assets
-386.56%-375.58%-4533.41%-571000.00%-361.27%
Earnings Yield
-22.41%-12.47%-272.65%-8.79%-0.53%
Efficiency Ratios
Receivables Turnover
96.04 46.69 156.08 0.00 0.00
Payables Turnover
0.33 0.57 1.59 0.21 0.30
Inventory Turnover
3.44 3.28 6.14 0.00 0.00
Fixed Asset Turnover
12.03 11.61 11.66 0.00 0.00
Asset Turnover
5.24 4.51 4.60 0.70 0.71
Working Capital Turnover Ratio
-0.46 -0.52 -1.60 -0.14 -1.56
Cash Conversion Cycle
-982.19 -521.76 -167.07 -1.74K -1.21K
Days of Sales Outstanding
3.80 7.82 2.34 0.00 0.00
Days of Inventory Outstanding
105.98 111.24 59.48 0.00 0.00
Days of Payables Outstanding
1.09K 640.82 228.89 1.74K 1.21K
Operating Cycle
109.78 119.06 61.82 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
<0.01 <0.01 >-0.01 >-0.01 >-0.01
Free Cash Flow Per Share
<0.01 <0.01 >-0.01 >-0.01 >-0.01
CapEx Per Share
<0.01 <0.01 <0.01 0.00 0.00
Free Cash Flow to Operating Cash Flow
0.68 0.77 1.58 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
3.08 4.30 -1.71 0.00 0.00
Capital Expenditure Coverage Ratio
3.08 4.30 -1.71 0.00 0.00
Operating Cash Flow Coverage Ratio
0.01 0.02 -0.15 -0.06 -0.27
Operating Cash Flow to Sales Ratio
0.02 0.02 -0.14 -0.60 -1.53
Free Cash Flow Yield
0.32%0.24%-6.07%-0.21%-0.44%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-4.62 -8.06 -0.37 -11.37 -189.46
Price-to-Sales (P/S) Ratio
3.30 6.68 3.61 291.99 351.91
Price-to-Book (P/B) Ratio
-1.28 -2.73 -2.50 -29.26 -73.61
Price-to-Free Cash Flow (P/FCF) Ratio
309.25 413.85 -16.47 -486.60 -229.47
Price-to-Operating Cash Flow Ratio
208.38 317.67 -26.09 -486.60 -229.47
Price-to-Earnings Growth (PEG) Ratio
-0.03 0.09 >-0.01 -0.02 7.58
Price-to-Fair Value
-1.28 -2.73 -2.50 -29.26 -73.61
Enterprise Value Multiple
-23.53 -32.72 -0.46 -12.06 -208.30
Enterprise Value
7.95M 14.53M 10.56M 6.72M 15.08M
EV to EBITDA
-23.53 -32.72 -0.46 -12.06 -208.30
EV to Sales
4.50 7.83 4.51 302.12 357.61
EV to Free Cash Flow
421.70 485.55 -20.57 -503.48 -233.19
EV to Operating Cash Flow
284.85 372.71 -32.58 -503.48 -233.19
Tangible Book Value Per Share
>-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Shareholders’ Equity Per Share
>-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.00 0.00 0.00
Revenue Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Net Income Per Share
>-0.01 >-0.01 -0.02 >-0.01 >-0.01
Tax Burden
1.00 1.00 1.00 1.00 1.00
Interest Burden
3.46 2.97 1.01 1.01 1.00
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
1.03 1.08 2.50 4.81 1.32
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
-0.02 -0.03 0.01 0.87 0.55
Currency in USD